MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202421017477 A) filed by Milind Vishu Sawant, Navi Mumbai, Maharashtra, on March 11, 2024, for 'a novel oral nutrition supplement formulation for sickle cell anemia symptoms.'
Inventor(s) include Milind Vishu Sawant.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a novel oral nutrition formulation for treating sickle cell anemia. The oral nutrition formulation includes an antioxidant one, a calcium, an anti-inflammatory one, an antioxidant two, an anti-inflammatory two, an antioxidant three, a vitamin B12, a folic acid, a protein, and an omega 3FA. A zinc having a concentration range from 7.0 mg to 21.0 mg, a calcium having a concentration range from 475.0 mg to 14250.0 mg, a magnesium having a concentration range from 190.0 mg to 580.0 mg, a vitamin C having a concentration range from 35.0 mg to 100.0 mg, a vitamin D having a concentration range from 285.0 mg to 855.0 mg, a vitamin E having a concentration range from 4.0 mg to 12.0 mg, a vitamin b12 having a concentration range from 1.0 mg to 3.0 mg, a folic acid having a concentration range from 125.0 mg to 375.0 mg, a protein having a concentration range from 12.0 gm to 36.0 gm, and an omega 3FA having a concentration range from 1.0 gm to 3.0 gm."
Disclaimer: Curated by HT Syndication.
